The Experts below are selected from a list of 321 Experts worldwide ranked by ideXlab platform
Sarah Masefield - One of the best experts on this subject based on the ideXlab platform.
-
statement on smoking cessation in copd and other Pulmonary Diseases and in smokers with comorbidities who find it difficult to quit
European Respiratory Journal, 2015Co-Authors: Carlos A Jimenezruiz, S Andreas, Keir Lewis, Philip Tonnesen, C P Van Schayck, Peter Hajek, Serena Tonstad, Bertrand Dautzenberg, Monica Fletcher, Sarah MasefieldAbstract:Chronic obstructive Pulmonary disease (COPD), lung cancer, asthma and Pulmonary tuberculosis are common Pulmonary Diseases that are caused or worsened by tobacco smoking. Growing observational evidence suggests that symptoms and prognosis of these conditions improve upon smoking cessation. Despite increasing numbers of (small) randomised controlled trials suggesting intensive smoking cessation treatments work in people with Pulmonary Diseases many patients are not given specific advice on the benefits or referred for intensive cessation treatments and, therefore, continue smoking. This is a qualitative review regarding smoking cessation in patients with COPD and other Pulmonary disorders, written by a group of European Respiratory Society experts. We describe the epidemiological links between smoking and Pulmonary disorders, the evidence for benefits of stopping smoking, how best to assess tobacco dependence and what interventions currently work best to help Pulmonary patients quit. Finally, we describe characteristics and management of any "hardcore" smoker who finds it difficult to quit with standard approaches.
S Andreas - One of the best experts on this subject based on the ideXlab platform.
-
statement on smoking cessation in copd and other Pulmonary Diseases and in smokers with comorbidities who find it difficult to quit
European Respiratory Journal, 2015Co-Authors: Carlos A Jimenezruiz, S Andreas, Keir Lewis, Philip Tonnesen, C P Van Schayck, Peter Hajek, Serena Tonstad, Bertrand Dautzenberg, Monica Fletcher, Sarah MasefieldAbstract:Chronic obstructive Pulmonary disease (COPD), lung cancer, asthma and Pulmonary tuberculosis are common Pulmonary Diseases that are caused or worsened by tobacco smoking. Growing observational evidence suggests that symptoms and prognosis of these conditions improve upon smoking cessation. Despite increasing numbers of (small) randomised controlled trials suggesting intensive smoking cessation treatments work in people with Pulmonary Diseases many patients are not given specific advice on the benefits or referred for intensive cessation treatments and, therefore, continue smoking. This is a qualitative review regarding smoking cessation in patients with COPD and other Pulmonary disorders, written by a group of European Respiratory Society experts. We describe the epidemiological links between smoking and Pulmonary disorders, the evidence for benefits of stopping smoking, how best to assess tobacco dependence and what interventions currently work best to help Pulmonary patients quit. Finally, we describe characteristics and management of any "hardcore" smoker who finds it difficult to quit with standard approaches.
-
[Smoking and Pulmonary Diseases, positive effects of smoking cessation].
Pneumologie, 2007Co-Authors: S AndreasAbstract:More than 30 % of the German population are regular smokers, over half of whom will eventually die of smoking-related Diseases. Life expectancy is abridged by 10 years in smokers compared to non-smokers. Smoking tobacco is the main risk factor for lung cancer and chronic obstructive Pulmonary disease (COPD) and predisposes to a number of other lung Diseases. A smoking cessation programme including pharmacological as well as psychosocial support is highly effective in COPD Patients. Smoking cessation improves lung function, symptoms and mortality. In conclusion, smoking cessation services are among the most effective medical interventions. Thus, a sufficient supply of smoking cessation services on a population level must be ensured.
Rebecca D Prevots - One of the best experts on this subject based on the ideXlab platform.
-
poor adherence to management guidelines in nontuberculous mycobacterial Pulmonary Diseases
European Respiratory Journal, 2017Co-Authors: Jakko Van Ingen, Dirk Wagner, Jack R Gallagher, Kozo Morimoto, Christoph Lange, Charles Haworth, Andres R Floto, Jennifer Adjemian, Rebecca D PrevotsAbstract:Poor adherence to diagnosis and treatment guidelines for nontuberculous mycobacterial lung disease in EU and Japan http://ow.ly/EVYl306vVcN
Carlos A Jimenezruiz - One of the best experts on this subject based on the ideXlab platform.
-
statement on smoking cessation in copd and other Pulmonary Diseases and in smokers with comorbidities who find it difficult to quit
European Respiratory Journal, 2015Co-Authors: Carlos A Jimenezruiz, S Andreas, Keir Lewis, Philip Tonnesen, C P Van Schayck, Peter Hajek, Serena Tonstad, Bertrand Dautzenberg, Monica Fletcher, Sarah MasefieldAbstract:Chronic obstructive Pulmonary disease (COPD), lung cancer, asthma and Pulmonary tuberculosis are common Pulmonary Diseases that are caused or worsened by tobacco smoking. Growing observational evidence suggests that symptoms and prognosis of these conditions improve upon smoking cessation. Despite increasing numbers of (small) randomised controlled trials suggesting intensive smoking cessation treatments work in people with Pulmonary Diseases many patients are not given specific advice on the benefits or referred for intensive cessation treatments and, therefore, continue smoking. This is a qualitative review regarding smoking cessation in patients with COPD and other Pulmonary disorders, written by a group of European Respiratory Society experts. We describe the epidemiological links between smoking and Pulmonary disorders, the evidence for benefits of stopping smoking, how best to assess tobacco dependence and what interventions currently work best to help Pulmonary patients quit. Finally, we describe characteristics and management of any "hardcore" smoker who finds it difficult to quit with standard approaches.
Jennifer Adjemian - One of the best experts on this subject based on the ideXlab platform.
-
poor adherence to management guidelines in nontuberculous mycobacterial Pulmonary Diseases
European Respiratory Journal, 2017Co-Authors: Jakko Van Ingen, Dirk Wagner, Jack R Gallagher, Kozo Morimoto, Christoph Lange, Charles Haworth, Andres R Floto, Jennifer Adjemian, Rebecca D PrevotsAbstract:Poor adherence to diagnosis and treatment guidelines for nontuberculous mycobacterial lung disease in EU and Japan http://ow.ly/EVYl306vVcN
